
The company is an AIM-listed supplier of specialty adhesive products, committed to being the leader in each of the segments in which it operates. The company invests heavily in its research and development activities, to create technically advanced solutions for its customers in automotive, medical, construction and general industry markets. The company employs over 1500 people in over 10 countries, worldwide.
Faced with highly global competitive markets, increasing raw material prices and following several Board changes, the task was to find a tough, commercially minded Group Finance Director to lead the finance Function and guide the business through a continuing process of restructuring. The appointee was found within the nuclear industry, bringing extensive experience of change management, wide international experience and a level of general management experience which qualifies him to act as successor to the CEO.
Board's Eye View is Odgers Berndtson's review of the latest news and views from the UK boardroom.
The world of healthcare is changing and the pace of change is swift. Boards up and down the country are faced with a series of challenges regarding...
The publication of an update to last year’s Open Public Services White Paper attests to the Government’s continued commitment to the marketisation of...